MLchartDataset catalogue

porfiromycin

Term · Oncology and biomedicine · MLC-T-ONC-006823

  1. A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called anticancer antibiotics.

  2. An N-methyl derivative of the antineoplastic antibiotic mitomycin C isolated from the bacterium Streptomyces ardus and other Streptomyces bacterial species. Bioreduced porfiromycin generates oxygen radicals and alkylates DNA, producing interstrand cross-links and single-strand breaks, thereby inhibiting DNA synthesis. Porfiromycin is preferentially toxic to hypoxic cells.

Table 1. Record
IdentifierMLC-T-ONC-006823
FieldOncology and biomedicine
Synonymsmethyl mitomycin C; methyl mitomycin; Methylmitomycin; porfiromycine; porphyromycin
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-006823",
  "term": "porfiromycin",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called anticancer antibiotics.",
    "An N-methyl derivative of the antineoplastic antibiotic mitomycin C isolated from the bacterium Streptomyces ardus and other Streptomyces bacterial species. Bioreduced porfiromycin generates oxygen radicals and alkylates DNA, producing interstrand cross-links and single-strand breaks, thereby inhibiting DNA synthesis. Porfiromycin is preferentially toxic to hypoxic cells."
  ],
  "synonyms": [
    "methyl mitomycin C",
    "methyl mitomycin",
    "Methylmitomycin",
    "porfiromycine",
    "porphyromycin"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/porfiromycin/"
}

Record 13,500 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.